We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APGE icon
301
Apogee Therapeutics
APGE
$10.2B
$1.04M 0.08%
+26,241
New +$1M
RBRK icon
302
Rubrik
RBRK
$18.5B
$1.03M 0.08%
12,563
+3,136
+33% +$270K
NXRT
303
NexPoint Residential Trust
NXRT
$652M
$1.03M 0.08%
+31,902
New +$1.05M
TPR icon
304
Tapestry
TPR
$32.8B
$1.03M 0.08%
9,078
+5,230
+136% +$547K
DIN icon
305
Dine Brands
DIN
$452M
$1.02M 0.08%
+41,427
New +$971K
JPM icon
306
JPMorgan Chase
JPM
$950B
$1.02M 0.08%
3,240
+816
+34% +$243K
CHKP icon
307
Check Point Software Technologies
CHKP
$13.1B
$1.02M 0.08%
4,925
+1,169
+31% +$236K
EXE
308
Expand Energy Corp
EXE
$21.5B
$1.02M 0.08%
9,567
+7,795
+440% +$782K
ARWR icon
309
Arrowhead Research
ARWR
$12.4B
$988K 0.08%
+28,658
New +$630K
PRO
310
DELISTED
PROS Holdings
PRO
$980K 0.08%
+42,787
New +$696K
WSR
311
DELISTED
Whitestone REIT
WSR
$977K 0.08%
79,549
+20,400
+34% +$257K
SNDK
312
Sandisk
SNDK
$177B
$974K 0.08%
8,685
-10,071
-54% -$588K
NXST icon
313
Nexstar Media Group
NXST
$5.97B
$970K 0.08%
+4,903
New +$959K
SNV
314
DELISTED
Synovus
SNV
$962K 0.08%
19,610
+14,516
+285% +$744K
PWR icon
315
Quanta Services
PWR
$101B
$949K 0.07%
2,289
-447
-16% -$174K
ASPI icon
316
ASP Isotopes
ASPI
$558M
$947K 0.07%
98,396
-7,056
-7% -$65.1K
PCRX icon
317
Pacira BioSciences
PCRX
$997M
$942K 0.07%
36,535
+12,300
+51% +$302K
NET icon
318
Cloudflare
NET
$107B
$935K 0.07%
4,357
-1,086
-20% -$222K
RVMD icon
319
Revolution Medicines
RVMD
$44B
$934K 0.07%
+20,000
New +$783K
NTES icon
320
NetEase
NTES
$84.7B
$934K 0.07%
+6,142
New +$845K
ANET icon
321
Arista Networks
ANET
$238B
$933K 0.07%
6,406
+1,855
+41% +$239K
BCS icon
322
Barclays
BCS
$94.1B
$931K 0.07%
45,065
-44,935
-50% -$890K
BIDU icon
323
Baidu
BIDU
$37.2B
$926K 0.07%
7,028
-120,024
-94% -$11.9M
FRO icon
324
Frontline
FRO
$8.85B
$924K 0.07%
40,561
-16,606
-29% -$336K
NTRA icon
325
Natera
NTRA
$46.4B
$922K 0.07%
5,730
+266
+5% +$42.1K
11 12
13
14 15

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.